Shenzhen Chipscreen Biosciences Co., Ltd. (688321.SS)

CNY 19.97

(1.01%)

Revenue Summary of Shenzhen Chipscreen Biosciences Co., Ltd.

  • Shenzhen Chipscreen Biosciences Co., Ltd.'s latest annual revenue in 2023 was 515.78 Million CNY , down -2.67% from previous year.
  • Shenzhen Chipscreen Biosciences Co., Ltd.'s latest quarterly revenue in 2024 Q2 was 169.47 Million CNY , up 31.73% from previous quarter.
  • Shenzhen Chipscreen Biosciences Co., Ltd. reported a annual revenue of 529.93 Million CNY in annual revenue 2022, up 23.11% from previous year.
  • Shenzhen Chipscreen Biosciences Co., Ltd. reported a annual revenue of 430.44 Million CNY in annual revenue 2021, up 59.74% from previous year.
  • Shenzhen Chipscreen Biosciences Co., Ltd. reported a quarterly revenue of 178.95 Million CNY for 2024 Q3, up 5.6% from previous quarter.
  • Shenzhen Chipscreen Biosciences Co., Ltd. reported a quarterly revenue of 128.64 Million CNY for 2024 Q1, down -25.61% from previous quarter.

Annual Revenue Chart of Shenzhen Chipscreen Biosciences Co., Ltd. (2023 - 2016)

Historical Annual Revenue of Shenzhen Chipscreen Biosciences Co., Ltd. (2023 - 2016)

Year Revenue Revenue Growth
2023 515.78 Million CNY -2.67%
2022 529.93 Million CNY 23.11%
2021 430.44 Million CNY 59.74%
2020 269.46 Million CNY 55.05%
2019 173.8 Million CNY 17.68%
2018 147.68 Million CNY 33.65%
2017 110.5 Million CNY 29.45%
2016 85.36 Million CNY 0.0%

Peer Revenue Comparison of Shenzhen Chipscreen Biosciences Co., Ltd.

Name Revenue Revenue Difference
Hubei Jumpcan Pharmaceutical Co., Ltd. 9.65 Billion CNY 94.658%
Yabao Pharmaceutical Group Co., Ltd 2.9 Billion CNY 82.274%
Guangzhou Baiyunshan Pharmaceutical Holdings Company Limited 75.51 Billion CNY 99.317%
Harbin Pharmaceutical Group Co., Ltd. 15.33 Billion CNY 96.637%
Tasly Pharmaceutical Group Co., Ltd 8.54 Billion CNY 93.964%
Zhejiang Medicine Co., Ltd. 7.79 Billion CNY 93.382%
Tianjin Pharmaceutical Da Ren Tang Group Corporation Limited 8.22 Billion CNY 93.727%
Lionco Pharmaceutical Group Co.,Ltd. 196.83 Million CNY -162.044%
Humanwell Healthcare (Group) Co.,Ltd. 24.33 Billion CNY 97.88%
Ginwa Enterprise (Group) Inc. 565.4 Million CNY 8.776%
Joincare Pharmaceutical Group Industry Co.,Ltd. 16.64 Billion CNY 96.902%
Zhejiang Shapuaisi Pharmaceutical Co.,Ltd. 644.97 Million CNY 20.03%
China Animal Husbandry Industry Co., Ltd. 5.4 Billion CNY 90.46%
Jiangsu Jibeier Pharmaceutical Co., Ltd. 860.93 Million CNY 40.09%
Zhejiang Huahai Pharmaceutical Co., Ltd. 8.21 Billion CNY 93.719%
Shanghai Haoyuan Chemexpress Co., Ltd. 1.87 Billion CNY 72.453%
Ningbo Menovo Pharmaceutical Co., Ltd. 1.21 Billion CNY 57.601%
Zhejiang Jiuzhou Pharmaceutical Co., Ltd 5.52 Billion CNY 90.662%
Chongqing Taiji Industry(Group) Co.,Ltd 15.43 Billion CNY 96.658%
HPGC Renmintongtai Pharmaceutical Corporation 10.38 Billion CNY 95.036%
Nanjing Well Pharmaceutical Group Co.,Ltd. 1.15 Billion CNY 55.376%
Tianjin Tianyao Pharmaceuticals Co., Ltd. 3.73 Billion CNY 86.188%
Henan Lingrui Pharmaceutical Co., Ltd. 3.31 Billion CNY 84.424%
Guizhou Yibai Pharmaceutical Co., Ltd. 2.77 Billion CNY 81.433%
Jiangsu Kanion Pharmaceutical Co.,Ltd. 4.86 Billion CNY 89.404%
Zhongzhu Healthcare Holding Co.,Ltd 580.05 Million CNY 11.08%
Beijing Tongrentang Co., Ltd 17.86 Billion CNY 97.112%
KPC Pharmaceuticals, Inc. 7.62 Billion CNY 93.239%
Shanghai Fudan-Zhangjiang Bio-Pharmaceutical Co.,Ltd. 845.34 Million CNY 38.985%
North China Pharmaceutical Company Ltd. 10.12 Billion CNY 94.903%
China Resources Double-Crane Pharmaceutical Co.,Ltd. 10.22 Billion CNY 94.954%
Tibet Weixinkang Medicine Co., Ltd. 1.32 Billion CNY 61.004%
China National Medicines Corporation Ltd. 49.69 Billion CNY 98.962%
Zhejiang Hisun Pharmaceutical Co., Ltd. 10.37 Billion CNY 95.028%
Heilongjiang ZBD Pharmaceutical Co., Ltd. 3.13 Billion CNY 83.564%
ChengDu ShengNuo Biotec Co.,Ltd. 430.98 Million CNY -19.675%
Dali Pharmaceuticalco.,Ltd 87.26 Million CNY -491.023%
Changchun BCHT Biotechnology Co. 1.81 Billion CNY 71.529%
Zhejiang Shengda Bio-Pharm Co., Ltd. 727.4 Million CNY 29.092%
Shanghai Jiaoda Onlly Co.,Ltd 291.91 Million CNY -76.688%
Jiang Zhong Pharmaceutical Co.,Ltd 4.32 Billion CNY 88.081%
Mayinglong Pharmaceutical Group Co., LTD. 3.13 Billion CNY 83.557%
Cisen Pharmaceutical Co., Ltd. 4.46 Billion CNY 88.441%
Hunan Warrant Pharmaceutical Co.,Ltd 1.43 Billion CNY 64.001%
Shanghai Fosun Pharmaceutical (Group) Co., Ltd. 41.39 Billion CNY 98.754%
Jianmin Pharmaceutical Group Co.,Ltd. 4.18 Billion CNY 87.673%
Hunan Fangsheng Pharmaceutical Co., Ltd. 1.62 Billion CNY 68.328%
Guangxi Wuzhou Zhongheng Group Co.,Ltd 3.09 Billion CNY 83.343%
Guobang Pharma Ltd. 5.34 Billion CNY 90.358%
Shaanxi Kanghui Pharmaceutical Co., Ltd. 672.96 Million CNY 23.356%
Kangmei Pharmaceutical Co., Ltd. 4.87 Billion CNY 89.418%
Shandong Buchang Pharmaceuticals Co., Ltd. 13.24 Billion CNY 96.106%
Zhejiang Starry Pharmaceutical Co.,Ltd. 2.17 Billion CNY 76.313%
Henan Taloph Pharmaceutical Stock Co.,Ltd 2.06 Billion CNY 75.082%
ZhuZhou QianJin Pharmaceutical Co.,Ltd 3.79 Billion CNY 86.421%
Nanjing King-Friend Biochemical Pharmaceutical Co., Ltd 3.93 Billion CNY 86.88%
Beijing Sun-Novo Pharmaceutical Research Co., Ltd. 932.12 Million CNY 44.665%
Shanghai Shyndec Pharmaceutical Co., Ltd. 11.93 Billion CNY 95.677%
Shanghai Yizhong Pharmaceutical Co., Ltd. 360.25 Million CNY -43.173%
Tibet Rhodiola Pharmaceutical Holding Co. 3.09 Billion CNY 83.341%
Sichuan Huiyu Pharmaceutical Co., Ltd. 920.34 Million CNY 43.958%
Zhejiang Cheng Yi Pharmaceutical Co., Ltd. 671.62 Million CNY 23.204%
CanSino Biologics Inc. 345.18 Million CNY -49.424%
Jiangsu Lianhuan Pharmaceutical Co., Ltd. 2.17 Billion CNY 76.276%
Shandong Lukang Pharmaceutical Co.,Ltd. 6.14 Billion CNY 91.609%